NAOV Stock: NanoVibronix, Inc. Stock Price, Analysis & Insights
Get live naov stock price $4.26, comprehensive NanoVibronix, Inc. stock analysis, charts, news, and expert forecast. Real-time naov stock data and investment insights.
Loading chart...
Company Overview
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
Company Information
- CEO
- Doron Robert Besser
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 31
Contact Information
- Website
- https://www.nanovibronix.com
- Address
- 525 Executive Boulevard
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 2.05)
Business Model & Strategy
NanoVibronix, Inc. operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Doron Robert Besser, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
NanoVibronix, Inc. competes in the Medical - Devices within the broader Healthcare. With 3.4 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, NanoVibronix, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating NanoVibronix, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for NanoVibronix, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for NanoVibronix, Inc.
- ⚠Investors should consider how NanoVibronix, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
3.40M
P/E Ratio
-0.08
Beta
2.05
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 3.40M market capitalization
- Trading Volume: 40.10K shares traded today
- Price Range: 52-week range of $3.55 - $162.50
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for NanoVibronix, Inc.
NanoVibronix, Inc. (NAOV) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 3.40M, the company represents a significant player in its market. The stock is currently trading at $4.26 with a negativedaily change of 14.45%.
The company's 31 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.08, beta of 2.05, and 52-week price range from $3.55 to $162.50when evaluating investment opportunities.
Why Invest in NanoVibronix, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Doron Robert Besser
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.